Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 9Cyclophosphamide 9Whole-Body Irradiation 8Mycophenolic Acid 8Cyclosporine 8Cord Blood Stem Cell Transplantation 7fludarabine 5Peripheral Blood Stem Cell Transplantation 4Busulfan 4Arsenic Trioxide 4Antilymphocyte Serum 4Transplantation 3Thiotepa 3Tacrolimus 3Radiotherapy 3Etoposide 3Cytarabine 3Methylprednisolone 2Methotrexate 2Melphalan 2Carmustine 2Azacitidine 2thymoglobulin 1lonafarnib 1lintuzumab 1itacitinib 1Vorinostat 1Tretinoin 1Tetradecanoylphorbol Acetate 1Teriparatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anemia, Refractory, with Excess of Blasts × Basiliximab × Clear all
NCT00594308 2014-10-06

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Indiana University

Phase NA Terminated
10 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡